Skip to main content

Table 4 Subjects with QTc >60 ms from baseline based on different QT correction formulae

From: Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine

Age (yrs)

Sex

Drug

QTc day 0 (ms)

QTc day 3 (ms)

Δ QTc(day3-day0)

DEAQ (ng/ml)

3.5

Male

A-A

361B

413B

52

109

   

315F

379F

64

 
   

373H

390H

17

 

5.5

Female

A-A

353B

399B

46

162

   

310F

386F

76

 
   

363H

385H

22

 

6.0

Female

A-A

404B

464B

60

0

   

357F

426F

69

 
   

394H

430H

36

 

6.5

Male

A-A

361B

443B

82

241

   

315F

397F

82

 
   

373H

416H

43

 

9.0

Male

A-L

366B

443B

77

NA

   

335F

413F

78

 
   

355H

414H

59

 

10.0

Female

A-L

387B

450B

63

NA

   

347F

418F

71

 
   

376H

419H

43

 
  1. B=Bazett’s QTc; F=Fridericia’s QTC; H=Hodges QTc; ΔQTc =change in QTc; A-A=artesunate-amodiaquine; A-L=artemether-lumefantrine; DEAQ=desethylamodiaquine concentration; NA=Not applicable.